Active 0 6 0 6 O
ocular 7 13 7 13 B-chronic_disease
infection 14 23 14 23 I-chronic_disease
or 24 26 24 26 O
ocular 27 33 27 33 B-chronic_disease
allergies 34 43 34 43 I-chronic_disease

Aged 0 4 44 48 B-age
18 5 7 49 51 B-lower_bound
years 8 13 52 57 I-lower_bound
or 14 16 58 60 O
older 17 22 61 66 O

Allergic 0 8 67 75 O
to 9 11 76 78 O
Deoxyribonuclease 12 29 79 96 B-allergy_name
eye 30 33 97 100 O
drops 34 39 101 106 O
or 40 42 107 109 O
any 43 46 110 113 O
similar 47 54 114 121 O
products 55 63 122 130 O

Any 0 3 131 134 O
history 4 11 135 142 O
of 12 14 143 145 O
eyelid 15 21 146 152 B-treatment
surgery 22 29 153 160 I-treatment
or 30 32 161 163 O
ocular 33 39 164 170 B-treatment
surgery 40 47 171 178 I-treatment
within 48 54 179 185 O
the 55 58 186 189 O
past 59 63 190 194 B-upper_bound
3 64 65 195 196 I-upper_bound
months 66 72 197 203 I-upper_bound

Corneal 0 7 204 211 B-clinical_variable
epithelial 8 18 212 222 I-clinical_variable
defect 19 25 223 229 O
larger 26 32 230 236 O
than 33 37 237 241 O
1 38 39 242 243 B-lower_bound
mm2 40 43 244 247 I-lower_bound
in 44 46 248 250 O
either 47 53 251 257 O
eye 54 57 258 261 O

Documented 0 10 262 272 O
Dry 11 14 273 276 B-chronic_disease
Eye 15 18 277 280 I-chronic_disease
Disease 19 26 281 288 O
for 27 30 289 292 O
at 31 33 293 295 O
least 34 39 296 301 O
6 40 41 302 303 B-lower_bound
months 42 48 304 310 I-lower_bound

Ocular 0 6 311 317 O
symptoms 7 15 318 326 O
must 16 20 327 331 O
be 21 23 332 334 O
considered 24 34 335 345 O
as 35 37 346 348 O
annoying 38 46 349 357 O
or 47 49 358 360 O
activity 50 58 361 369 O
limiting 59 67 370 378 O
( 68 69 379 380 O
OSDI 69 73 380 384 B-clinical_variable
≥13 74 77 385 388 O
; 77 78 388 389 O
mild 79 83 390 394 O
) 83 84 394 395 O

Receiving 0 9 396 405 O
or 10 12 406 408 O
have 13 17 409 413 O
received 18 26 414 422 O
within 27 33 423 429 O
30 34 36 430 432 B-upper_bound
days 37 41 433 437 I-upper_bound
any 42 45 438 441 O
experimental 46 58 442 454 O
systemic 59 67 455 463 B-treatment
medication 68 78 464 474 I-treatment

The 0 3 475 478 O
use 4 7 479 482 O
of 8 10 483 485 O
topical 11 18 486 493 B-treatment
cyclosporine 19 31 494 506 I-treatment
or 32 34 507 509 O
corticosteroids 35 50 510 525 B-treatment
within 51 57 526 532 O
2 58 59 533 534 B-upper_bound
weeks 60 65 535 540 I-upper_bound
of 66 68 541 543 O
enrollment 69 79 544 554 O

Women 0 5 555 560 B-gender
must 6 10 561 565 O
be 11 13 566 568 O
post 14 18 569 573 B-clinical_variable
- 18 19 573 574 I-clinical_variable
menopausal 19 29 574 584 I-clinical_variable
≥ 30 31 585 586 O
1 32 33 587 588 B-lower_bound
year 34 38 589 593 I-lower_bound

excipients 0 10 594 604 O
of 11 13 605 607 O
Deoxyribonuclease 14 31 608 625 B-clinical_variable
eye 32 35 626 629 I-clinical_variable
drops 36 41 630 635 I-clinical_variable
0.1 42 45 636 639 B-upper_bound
% 45 46 639 640 I-upper_bound

negative 0 8 641 649 B-pregnancy
urine 9 14 650 655 I-pregnancy
pregnancy 15 24 656 665 I-pregnancy
test 25 29 666 670 O
is 30 32 671 673 O
required 33 41 674 682 O
within 42 48 683 689 O
14 49 51 690 692 B-upper_bound
days 52 56 693 697 I-upper_bound
of 57 59 698 700 O
receiving 60 69 701 710 O
her 70 73 711 714 O
first 74 79 715 720 O
dose 80 84 721 725 O
of 85 87 726 728 O
test 88 92 729 733 O
medication 93 103 734 744 B-treatment
( 104 105 745 746 O
placebo/ 105 113 746 754 O
study 114 119 755 760 O
drug 120 124 761 765 O
) 124 125 765 766 O
along 126 131 767 772 O
with 132 136 773 777 O
definite 137 145 778 786 O
evidence 146 154 787 795 O
of 155 157 796 798 O
contraceptive 158 171 799 812 O
use 172 175 813 816 O
during 176 182 817 823 O
the 183 186 824 827 O
duration 187 195 828 836 O
of 196 198 837 839 O
the 199 202 840 843 O
study 203 208 844 849 O

surgically 0 10 850 860 B-treatment
sterilized 11 21 861 871 I-treatment

